Inhibitors of the PI3K/AKT/mTOR signaling pathway, such as dactolisib, have potential antineoplastic activity targeting tumor cell apoptosis and growth inhibition in PI3K/mTOR-overexpressing tumor cells. Here, AKT1 is linked to neoplasm.